Treatment of older patients with acute myeloid leukaemia
- 1 December 2010
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 376 (9757), 1967-1968
- https://doi.org/10.1016/s0140-6736(10)62104-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomesThe Lancet, 2010
- Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemiaBlood, 2010
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- AML in older patients: Are we making progress?Best Practice & Research Clinical Haematology, 2009
- Acute myelogenous leukemiaExperimental Hematology, 2009
- Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trialsBritish Journal of Haematology, 2009
- Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patientsBlood, 2009
- Clinically useful prognostic factors in acute myeloid leukemiaCritical Reviews in Oncology/Hematology, 2008
- Unanswered questions in acute myeloid leukaemiaThe Lancet Oncology, 2004
- Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndromeLeukemia, 2004